Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
ACCPL
ACCPL

Accretion Pharmaceuticals Ltd.

NSE: ACCPL
SME
Sector: Healthcare
Industry: Pharmaceuticals
192.00-8.0 (-4.00%)
25 Aug, 1:59 PM

Stock Scores

Quality Score

54.1 / 100

Value Score

34.1 / 100

Price Momentum Score

98.6 / 100

QVM Score

73.2 / 100

Key Metrics

Market Cap
222.32
P/E (TTM)
23.00
P/B
4.06
P/S (TTM)
2.48
EV/EBITDA
15.42
CAPE (5Y)
53.21
ROE (TTM)
27.62
ROCE (TTM)
28.50
ROA (TTM)
16.59
Avg 3Y ROE
59.27
Earnings 3Y CAGR
358.80
Sales 3Y CAGR
45.02
Sales 5Y CAGR
-
Debt/Equity
0.23
Consensus TP
-
Strong Buy %
-
Promoter Holding
73.52
Pledged %
0.00

Share Price

Track Accretion Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -4.00 %
Low
190.0
High
214.7
1 Month returns: 16.93 %
Low
160.0
High
214.7
1 Year returns: 223.50 %
Low
53.8
High
214.7
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Accretion Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Accretion Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Accretion Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Accretion Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Accretion Pharmaceuticals Ltd.?
The current share price of Accretion Pharmaceuticals Ltd. is ₹ 192.00 as of 25 Aug 2026.
What is the market capitalisation of Accretion Pharmaceuticals Ltd.?
The market capitalisation of Accretion Pharmaceuticals Ltd. stands at ₹ 222.32 Cr.
What is the PE ratio of Accretion Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Accretion Pharmaceuticals Ltd. is 23.00 as of the latest trailing twelve months data.
What is the ROE and ROCE of Accretion Pharmaceuticals Ltd.?
Accretion Pharmaceuticals Ltd. has a Return on Equity (ROE) of 27.62% and a Return on Capital Employed (ROCE) of 28.50% as per the latest financial reports.
What is the 52-week high and low of Accretion Pharmaceuticals Ltd.?
The 52-week high of Accretion Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Accretion Pharmaceuticals Ltd.?
The dividend yield of Accretion Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Accretion Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 22.89% of Accretion Pharmaceuticals Ltd. shares.
What sector does Accretion Pharmaceuticals Ltd. belong to?
Accretion Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Accretion Pharmaceuticals Ltd.?
The beta of Accretion Pharmaceuticals Ltd. is 0.59, indicating its price volatility relative to the broader market. Over the past 1 year, Accretion Pharmaceuticals Ltd. has delivered an absolute return of 235.85%.
What is the RSI of Accretion Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Accretion Pharmaceuticals Ltd. is 64.56, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.